Cover Image
市場調查報告書

非侵入性產前診斷的全球市場:2016∼2020年

Global Non-Invasive Prenatal Testing Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 369186
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
非侵入性產前診斷的全球市場:2016∼2020年 Global Non-Invasive Prenatal Testing Market 2016-2020
出版日期: 2016年08月30日 內容資訊: 英文 70 Pages
簡介

非侵入性產前診斷用是分析胎兒的無細胞DNA查出染色體的非整倍體的最新技術,有助於診斷遺傳基因疾病的風險。全球非侵入性產前診斷市場預計2016∼2020年以17.44%的年複合成長率擴大

本報告提供全球非侵入性產前診斷市場相關調查,市場的各檢驗產品,各終端用戶,各地區趨勢,今後的成長預測,以及加入此市場的主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 非侵入性產前診斷的全球市場:各檢驗產品市場區隔

  • MaterniT21Plus檢驗
  • NIFTY檢驗
  • Harmony檢驗
  • Bambni 檢驗
  • Verifi檢驗
  • Panorama檢驗
  • Prena檢驗

第7章 非侵入性產前診斷的全球市場:各終端用戶市場區隔

  • 醫院
  • 診斷臨床試驗所
  • 研究機關及學術機構

第8章 非侵入性產前診斷的全球市場:各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 非侵入性產前診斷的全球市場:促進要素

  • 孕婦的高齡化
  • 新生兒的染色體疾病發病率
  • NIPT的優點

第10章 促進要素的影響

第11章 非侵入性產前診斷的全球市場:課題

  • 障礙造成的中斷
  • 產前無細胞DNA篩檢的限制
  • 消費者的選項限制和有效的產品差異化不足

第12章 促進要素與課題的影響

第13章 非侵入性產前診斷的全球市場:趨勢

第14章 供應商環境

  • 競爭模式
  • 主要消息

第15章 主要供應商

  • BGI Genomics
  • Illumina
  • LifeCodexx
  • Natera
  • Sequenom
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

目錄
Product Code: IRTNTR9873

About NIPT

NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

Technavio's analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BGI Genomics
  • Illumina
  • LifeCodexx
  • Natera
  • Sequenom

Other Prominent Vendors

  • Ariosa Diagnostics
  • Berry Genomics
  • CombiMatrix
  • F. Hoffmann-La Roche
  • Genpharm Services
  • Laboratory Corporation of America Holdings
  • LifeLabs Genetics
  • Quest Diagnostics
  • Safembryo
  • Sengenics

Market driver

  • Incidence of fetal chromosomal disorders in newborns
  • For a full, detailed list, view our report

Market challenge

  • Limited consumer options and lack of effective product differentiation
  • For a full, detailed list, view our report

Market trend

  • Increase in partnerships and collaborations
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by testing product

  • Global NIPT market for MaterniT21 Plus test
  • Global NIPT market for NIFTY test
  • Global NIPT market for Harmony test
  • Global NIPT market for Bambni test
  • Global NIPT market for Verifi test
  • Global NIPT market for Panorama test
  • Global NIPT market for PrenaTest

PART 07: Market segmentation by end-user

  • Hospitals
  • Diagnostic clinical laboratories
  • Research laboratories and academia

PART 08: Geographical segmentation

  • NIPT market in Americas
  • NIPT market in EMEA
  • NIPT market in APAC

PART 09: Market drivers

  • Child-bearing at advanced maternal age
  • Incidence of fetal chromosomal disorders in newborns
  • Advantages of NIPTs

PART 10: Impact of drivers

PART 11: Market challenges

  • Pregnancy termination due to disability
  • Limitations of prenatal cell-free DNA screening
  • Limited consumer options and lack of effective product differentiation

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Increased volumes of prenatal care counselling in hospitals
  • Bioinformatics tools combined with DNA sequencing for NIPTs
  • Increase in partnerships and collaborations

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Major vendors

  • BGI Genomics
  • Illumina
  • LifeCodexx
  • Natera
  • Sequenom
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global NIPT market ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global NIPT market segmentation by testing product 2015
  • Exhibit 05: Global NIPT market segmentation by testing product 2020
  • Exhibit 06: Global NIPT market for Maternit21 Plus test: Metric analysis 2016-2020
  • Exhibit 07: Global NIPT market for Maternit21 Plus test 2015-2020 ($ millions)
  • Exhibit 08: Global NIPT market for NIFTY test: Metric analysis 2016-2020
  • Exhibit 09: Global NIPT market for NIFTY test 2015-2020 ($ millions)
  • Exhibit 10: Global NIPT market for Harmony test: Metric analysis 2016-2020
  • Exhibit 11: Global NIPT market for Harmony test 2015-2020 ($ millions)
  • Exhibit 12: Global NIPT market for Bambni test: Metric analysis 2016-2020
  • Exhibit 13: Global NIPT market for Bambni test 2015-2020 ($ millions)
  • Exhibit 14: Sensitivity and specificity of Verifi test
  • Exhibit 15: Global NIPT market for Verifi test: Metric analysis 2016-2020
  • Exhibit 16: Global NIPT market for Verifi test 2015-2020 ($ millions)
  • Exhibit 17: Global NIPT market for Panorama test: Metric analysis 2016-2020
  • Exhibit 18: Global NIPT market for Panorama test 2015-2020 ($ millions)
  • Exhibit 19: Detection rate of Panorama test
  • Exhibit 20: Global NIPT market for PrenaTest: Metric analysis 2016-2020
  • Exhibit 21: Global NIPT market for PrenaTest 2015-2020 ($ millions)
  • Exhibit 22: Global NIPT market segmentation by geography 2015
  • Exhibit 23: Global NIPT market segmentation by geography 2020
  • Exhibit 24: NIPT market in Americas 2015-2020 ($ millions)
  • Exhibit 25: NIPT market in EMEA 2015-2020 ($ millions)
  • Exhibit 26: NIPT market in APAC 2015-2020 ($ millions)
  • Exhibit 27: Non-invasive and invasive prenatal tests
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Impact of drivers and challenges
  • Exhibit 30: Global NIPT market: Competitive landscape analysis 2015
  • Exhibit 31: BGI Genomics: Metrics analysis
  • Exhibit 32: Illumina: Metrics analysis
  • Exhibit 33: LifeCodexx: Metrics analysis
  • Exhibit 34: Natera: Metrics analysis
  • Exhibit 35: Sequenom: Metrics analysis
  • Exhibit 36: Other prominent vendors
Back to Top